Japan Lifeline Co., Ltd. announced today that at the board of directors meeting held on March 26, it has decided to make the following changes to its personnel.
In addition, Japan Lifeline has made a change to the current operating officer system so that term of office is one year from April 1 to March 31 of the following year. As a result, the current six operating officers, whose term of office is June 30, 2021, will be dismissed on March 31 and reappointed on April 1 of the same year.
1.
Changes in personnel (Effective on April 1, 2021) (1) Operating officer
(Reappointment)
New position and title
Name
Old position and title
Operating Officer, General Manager of Ichihara R&D and Manufacturing Department of R&D and Manufacturing Headquarters
Kunio Kuwahara
Operating Officer, General Manager of Ichihara R&D and Manufacturing Department of R&D and Manufacturing Headquarters
Operating Officer, Associate Senior General Manager of Arrhythmia Business Unit, General Manager of Arrhythmia Sales Department
Tsutomu Hoshino
Operating Officer, Associate Senior General Manager of Arrhythmia Business Unit, General Manager of Arrhythmia Sales Department
Operating Officer, Senior Manager of EP Sales Promotion Division of Arrhythmia Business Unit, Senior Manager of West Japan Sales Division
Takahiko Suzuki
Operating Officer, Senior Manager of West Japan Sales Division of Arrhythmia Sales Department of Arrhythmia Business Unit, Senior Branch Manager of Chugoku Branch
Operating Officer, Senior Manager of EP Department of Arrhythmia Business Unit, General Manager of EP Marketing Division
Naohiro Nakada
Operating Officer, Senior Manager of EP Department of Arrhythmia Business Unit
New position and title
Name
Old position and title
Operating Officer, General Manager of CRM Department of Arrhythmia Business Unit
Takashi Ito
Operating Officer, General Manager of CRM Department of Arrhythmia Business Unit
Operating Officer, General Manager of CVE Department of CVG Business Unit, General Manager of CVE Marketing Division
Tatsuya Murase
Operating Officer, General Manager of CVE Department of CV Business Unit, General Manager of CVE Marketing Division
(New appointment)
New position and title
Name
Old position and title
Operating Officer, General Manager of Research & Development Department of R&D and Manufacturing Headquarters, General Manager of R&D Division II
Kenji Mori
General Manager of Research & Development Department of R&D and Manufacturing Headquarters, General Manager of R&D Division II
Operating Officer, General Manager of Regulatory Affairs Division of Regulatory Affairs Headquarters
Toshihiro Miyake
General Manager of Regulatory Affairs Division of Regulatory Affairs Headquarters
Attachments
Original document
Permalink
Disclaimer
JLL - Japan Lifeline Co. Ltd. published this content on 26 March 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 26 March 2021 06:12:05 UTC.
Japan Lifeline Co., Ltd. is a Japan-based company mainly engaged in the import, manufacture and sale of cardiac circulators and other medical devices. The Company is mainly engaged in the production of rhythm devices, electrophysiological (EP) and ablations, surgical products and intervention products. The rhythm devices include cardiac pacemakers, implantable cardioverter defibrillator (ICD), cardiac resynchronization therapy defibrillator (CRT-D) and other rhythm devices. The EP and ablations include EP catheters for cardiac arrhythmia examination, ablation catheters for arrhythmia treatment and other EP and ablations. The surgical products include prosthetic heart valves and annuloplasty rings for heart disease surgical treatment, vascular grafts, open stent grafts and stent grafts for aortic disease treatment, as well as other surgical products. The intervention products include balloon catheters, guide wires, penetration catheters and other intervention products.
JAPAN LIFELINE CO., LTD. 
